| Name | mutS homolog 2 |
| Description | This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMSH2 is a central component of the DNA mismatch repair (MMR) system that safeguards genomic integrity by detecting and initiating repair of replication errors. Germline inactivation of MSH2 predisposes individuals to Lynch syndrome, which is characterized by an elevated risk for colorectal, endometrial, and other cancers. In this context, accurate cancer risk estimates are essential for clinical management and surveillance of affected families."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAt the molecular level, MSH2 functions by forming heterodimers with partner proteins such as MSH6 and MSH3 to recognize mismatches and insertion/deletion loops. In addition, it coordinates with other repair factors like hMYH to correct oxidatively damaged bases and interacts with key signaling kinases—including ATR—to initiate downstream phosphorylation events essential for cell cycle checkpoint activation. Moreover, posttranscriptional regulation by microRNAs (for example, miR-21) can downregulate MSH2 expression, thereby influencing both the repair capacity and chemosensitivity of tumor cells."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nPathogenic mutations in MSH2—including point mutations, deletions and rearrangements—result in loss of protein function and the subsequent development of microsatellite instability and a hypermutator phenotype that drives tumorigenesis. Such inactivation not only promotes an increased risk for colorectal and endometrial cancers but is also linked to syndromic presentations such as Muir–Torre syndrome, and has been implicated in the hypermutated subsets of other malignancies including prostate cancer. The identification of founder mutations and the characterization of MSH2 mutation spectra have enhanced genetic testing, risk stratification, and family counseling in Lynch syndrome."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "23"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its direct role in mismatch correction, MSH2 has been pivotal in refining diagnostic protocols and risk assessments for hereditary cancers. Studies combining immunohistochemistry, microsatellite instability testing, and comprehensive gene dosage analyses have underscored the importance of MSH2 status for both prognostication and therapeutic decision‐making. These investigations, which also explore alternate splicing, epigenetic modifications and crosstalk with other repair pathways, have broadened our understanding of MSH2 biology and illuminated its impact on tumor sensitivity to chemotherapeutics and immunotherapy. Together with insights derived from mutation screening and founder effect analyses, this body of work reinforces the value of incorporating MSH2 functional status into clinical algorithms for the management of Lynch syndrome."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "24", "end_ref": "46"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Valérie Bonadona, Bernard Bonaïti, Sylviane Olschwang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "JAMA (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1001/jama.2011.743"}], "href": "https://doi.org/10.1001/jama.2011.743"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21642682"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21642682"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Marjolijn J L Ligtenberg, Roland P Kuiper, Tsun Leung Chan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ng.283"}], "href": "https://doi.org/10.1038/ng.283"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19098912"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19098912"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Heather Hampel, Wendy Frankel, Jenny Panescu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-06-1114"}], "href": "https://doi.org/10.1158/0008-5472.CAN-06-1114"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16885385"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16885385"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Rebecca A Barnetson, Albert Tenesa, Susan M Farrington, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "N Engl J Med (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1056/NEJMoa053493"}], "href": "https://doi.org/10.1056/NEJMoa053493"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16807412"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16807412"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Fay Kastrinos, Bhramar Mukherjee, Nabihah Tayob, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Risk of pancreatic cancer in families with Lynch syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "JAMA (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1001/jama.2009.1529"}], "href": "https://doi.org/10.1001/jama.2009.1529"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19861671"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19861671"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Nicola Valeri, Pierluigi Gasparini, Chiara Braconi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1015541107"}], "href": "https://doi.org/10.1073/pnas.1015541107"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21078976"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21078976"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Yesong Gu, Antony Parker, Teresa M Wilson, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human MutY homolog, a DNA glycosylase involved in base excision repair, physically and functionally interacts with mismatch repair proteins human MutS homolog 2/human MutS homolog 6."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M108618200"}], "href": "https://doi.org/10.1074/jbc.M108618200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11801590"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11801590"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Yi Wang, Jun Qin "}, {"type": "b", "children": [{"type": "t", "text": "MSH2 and ATR form a signaling module and regulate two branches of the damage response to DNA methylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.2536810100"}], "href": "https://doi.org/10.1073/pnas.2536810100"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14657349"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14657349"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Enric Domingo, Renée C Niessen, Carla Oliveira, et al. "}, {"type": "b", "children": [{"type": "t", "text": "BRAF-V600E is not involved in the colorectal tumorigenesis of HNPCC in patients with functional MLH1 and MSH2 genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/sj.onc.1208569"}], "href": "https://doi.org/10.1038/sj.onc.1208569"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15782118"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15782118"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "J M Cunningham, C Y Kim, E R Christensen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1086/323658"}], "href": "https://doi.org/10.1086/323658"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11524701"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11524701"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Elena Stoffel, Bhramar Mukherjee, Victoria M Raymond, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2009.07.039"}], "href": "https://doi.org/10.1053/j.gastro.2009.07.039"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19622357"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19622357"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Colin C Pritchard, Colm Morrissey, Akash Kumar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms5988"}], "href": "https://doi.org/10.1038/ncomms5988"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25255306"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25255306"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "James G Dowty, Aung K Win, Daniel D Buchanan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cancer risks for MLH1 and MSH2 mutation carriers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mutat (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/humu.22262"}], "href": "https://doi.org/10.1002/humu.22262"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23255516"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23255516"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Daniel D Buchanan, Yen Y Tan, Michael D Walsh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2013.51.2129"}], "href": "https://doi.org/10.1200/JCO.2013.51.2129"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24323032"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24323032"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "R S van der Post, L A Kiemeney, M J L Ligtenberg, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Med Genet (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/jmg.2010.076992"}], "href": "https://doi.org/10.1136/jmg.2010.076992"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20591884"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20591884"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Isabelle Tournier, Myriam Vezain, Alexandra Martins, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mutat (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/humu.20796"}], "href": "https://doi.org/10.1002/humu.20796"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18561205"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18561205"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Henry T Lynch, Murray Joseph Casey, Carrie L Snyder, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Oncol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molonc.2009.02.004"}], "href": "https://doi.org/10.1016/j.molonc.2009.02.004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19383374"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19383374"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Brandie Heald, Thomas Plesec, Xiuli Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2012.45.1674"}], "href": "https://doi.org/10.1200/JCO.2012.45.1674"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23401454"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23401454"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Liana B Guedes, Emmanuel S Antonarakis, Michael T Schweizer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MSH2 Loss in Primary Prostate Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Cancer Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/1078-0432.CCR-17-0955"}], "href": "https://doi.org/10.1158/1078-0432.CCR-17-0955"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28790115"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28790115"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "W D Foulkes, I Thiffault, S B Gruber, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Hum Genet (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1086/345075"}], "href": "https://doi.org/10.1086/345075"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12454801"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12454801"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Christopher D South, Heather Hampel, Ilene Comeras, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The frequency of Muir-Torre syndrome among Lynch syndrome families."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Natl Cancer Inst (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/jnci/djm291"}], "href": "https://doi.org/10.1093/jnci/djm291"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18270343"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18270343"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Johanne Geary, Peter Sasieni, Richard Houlston, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gene-related cancer spectrum in families with hereditary non-polyposis colorectal cancer (HNPCC)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Fam Cancer (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10689-007-9164-6"}], "href": "https://doi.org/10.1007/s10689-007-9164-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17939062"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17939062"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Elisabeth Mangold, Constanze Pagenstecher, Waltraut Friedl, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.20863"}], "href": "https://doi.org/10.1002/ijc.20863"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15849733"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15849733"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "H F Vasen, A Stormorken, F H Menko, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2001.19.20.4074"}], "href": "https://doi.org/10.1200/JCO.2001.19.20.4074"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11600610"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11600610"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "E Domingo, P Laiho, M Ollikainen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Med Genet (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/jmg.2004.020651"}], "href": "https://doi.org/10.1136/jmg.2004.020651"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15342696"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15342696"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Aung Ko Win, Joanne P Young, Noralane M Lindor, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2011.39.5590"}], "href": "https://doi.org/10.1200/JCO.2011.39.5590"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22331944"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22331944"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Jörg Felsberg, Niklas Thon, Sabina Eigenbrod, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Cancer (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/ijc.26083"}], "href": "https://doi.org/10.1002/ijc.26083"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21425258"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21425258"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "E Barrow, L Robinson, W Alduaij, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Genet (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1399-0004.2008.01125.x"}], "href": "https://doi.org/10.1111/j.1399-0004.2008.01125.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19215248"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19215248"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Heikki J Järvinen, Laura Renkonen-Sinisalo, Katja Aktán-Collán, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2009.23.7784"}], "href": "https://doi.org/10.1200/JCO.2009.23.7784"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19720893"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19720893"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "W S Samowitz, K Curtin, H H Lin, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2001)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/gast.2001.27996"}], "href": "https://doi.org/10.1053/gast.2001.27996"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11606497"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11606497"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Melissa C Southey, Mark A Jenkins, Leeanne Mead, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2005.04.671"}], "href": "https://doi.org/10.1200/JCO.2005.04.671"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16116158"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16116158"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Hans F A Vasen, Mohamed Abdirahman, Richard Brohet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2010.02.053"}], "href": "https://doi.org/10.1053/j.gastro.2010.02.053"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20206180"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20206180"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Anthony Mazurek, Mark Berardini, Richard Fishel "}, {"type": "b", "children": [{"type": "t", "text": "Activation of human MutS homologs by 8-oxo-guanine DNA damage."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M111269200"}], "href": "https://doi.org/10.1074/jbc.M111269200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11756455"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11756455"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "C F Taylor, R S Charlton, J Burn, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genomic deletions in MSH2 or MLH1 are a frequent cause of hereditary non-polyposis colorectal cancer: identification of novel and recurrent deletions by MLPA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mutat (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/humu.10291"}], "href": "https://doi.org/10.1002/humu.10291"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14635101"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14635101"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Donald W Hadley, Jean Jenkins, Eileen Dimond, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Intern Med (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1001/archinte.163.5.573"}], "href": "https://doi.org/10.1001/archinte.163.5.573"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12622604"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12622604"}]}, {"type": "r", "ref": 36, "children": [{"type": "t", "text": "Shikha Gupta, Martin Gellert, Wei Yang "}, {"type": "b", "children": [{"type": "t", "text": "Mechanism of mismatch recognition revealed by human MutSβ bound to unpaired DNA loops."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Struct Mol Biol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nsmb.2175"}], "href": "https://doi.org/10.1038/nsmb.2175"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22179786"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22179786"}]}, {"type": "r", "ref": 37, "children": [{"type": "t", "text": "Fleur E M Rijcken, Marian J E Mourits, Jan H Kleibeuker, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gynecologic screening in hereditary nonpolyposis colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gynecol Oncol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0090-8258(03)00371-8"}], "href": "https://doi.org/10.1016/s0090-8258(03"}, {"type": "t", "text": "00371-8) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14529665"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14529665"}]}, {"type": "r", "ref": 38, "children": [{"type": "t", "text": "Darcy Whiteside, Ross McLeod, Gail Graham, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A homozygous germ-line mutation in the human MSH2 gene predisposes to hematological malignancy and multiple café-au-lait spots."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2002)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11809679"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11809679"}]}, {"type": "r", "ref": 39, "children": [{"type": "t", "text": "Jinru Shia, David S Klimstra, Khedoudja Nafa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Surg Pathol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/01.pas.0000146009.85309.3b"}], "href": "https://doi.org/10.1097/01.pas.0000146009.85309.3b"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15613860"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15613860"}]}, {"type": "r", "ref": 40, "children": [{"type": "t", "text": "Neil A J Ryan, Julie Morris, Kate Green, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "JAMA Oncol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1001/jamaoncol.2017.0619"}], "href": "https://doi.org/10.1001/jamaoncol.2017.0619"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28772289"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28772289"}]}, {"type": "r", "ref": 41, "children": [{"type": "t", "text": "R J Mitchell, S M Farrington, M G Dunlop, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: a HuGE review."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Epidemiol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/aje/kwf139"}], "href": "https://doi.org/10.1093/aje/kwf139"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12419761"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12419761"}]}, {"type": "r", "ref": 42, "children": [{"type": "t", "text": "Timm Goecke, Karsten Schulmann, Christoph Engel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: a report by the German HNPCC Consortium."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Oncol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1200/JCO.2005.03.7333"}], "href": "https://doi.org/10.1200/JCO.2005.03.7333"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16908935"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16908935"}]}, {"type": "r", "ref": 43, "children": [{"type": "t", "text": "Anastasia Zlatanou, Emmanuelle Despras, Tirzah Braz-Petta, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The hMsh2-hMsh6 complex acts in concert with monoubiquitinated PCNA and Pol η in response to oxidative DNA damage in human cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cell (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.molcel.2011.06.023"}], "href": "https://doi.org/10.1016/j.molcel.2011.06.023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21855803"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21855803"}]}, {"type": "r", "ref": 44, "children": [{"type": "t", "text": "Daniel L Edelstein, Jennifer Axilbund, Melanie Baxter, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Rapid development of colorectal neoplasia in patients with Lynch syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Gastroenterol Hepatol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cgh.2010.10.033"}], "href": "https://doi.org/10.1016/j.cgh.2010.10.033"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21070872"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21070872"}]}, {"type": "r", "ref": 45, "children": [{"type": "t", "text": "Nicola S Fearnhead, Jennifer L Wilding, Bruce Winney, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0407187101"}], "href": "https://doi.org/10.1073/pnas.0407187101"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15520370"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15520370"}]}, {"type": "r", "ref": 46, "children": [{"type": "t", "text": "Kristina Lagerstedt Robinson, Tao Liu, Jana Vandrovcova, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Natl Cancer Inst (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/jnci/djk051"}], "href": "https://doi.org/10.1093/jnci/djk051"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17312306"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17312306"}]}]}]}
|
| Synonyms | COCA1, LCFS2, hMSH2, HNPCC1, FCC1 |
| Proteins | MSH2_HUMAN |
| NCBI Gene ID | 4436 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MSH2 has 14,215 functional associations with biological entities spanning 9 categories (molecular profile, organism, chemical, disease, phenotype or trait, functional term, phrase or reference, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 140 datasets.
Click the + buttons to view associations for MSH2 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by MSH2 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of MSH2 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of MSH2 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MSH2 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of MSH2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of MSH2 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of MSH2 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of MSH2 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MSH2 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MSH2 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of MSH2 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MSH2 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of MSH2 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene Mutation Profiles | cell lines with MSH2 gene mutations from the CCLE Cell Line Gene Mutation Profiles dataset. | |
| CCLE Cell Line Proteomics | Cell lines associated with MSH2 protein from the CCLE Cell Line Proteomics dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with MSH2 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MSH2 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MSH2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of MSH2 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| ClinVar Gene-Phenotype Associations | phenotypes associated with MSH2 gene from the curated ClinVar Gene-Phenotype Associations dataset. | |
| ClinVar Gene-Phenotype Associations 2025 | phenotypes associated with MSH2 gene from the curated ClinVar Gene-Phenotype Associations 2025 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MSH2 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing MSH2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing MSH2 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Experimental Protein Localization Evidence Scores | cellular components containing MSH2 protein in low- or high-throughput protein localization assays from the COMPARTMENTS Experimental Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with MSH2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with MSH2 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| CORUM Protein Complexes | protein complexs containing MSH2 protein from the CORUM Protein Complexes dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MSH2 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with MSH2 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with MSH2 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with MSH2 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with MSH2 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by MSH2 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores | diseases involving MSH2 gene from the DISEASES Curated Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Curated Gene-Disease Association Evidence Scores 2025 | diseases involving MSH2 gene from the DISEASES Curated Gene-Disease Association Evidence Scores 2025 dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with MSH2 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores | diseases co-occuring with MSH2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with MSH2 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with MSH2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| DisGeNET Gene-Phenotype Associations | phenotypes associated with MSH2 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Phenoptype Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MSH2 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MSH2 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MSH2 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing MSH2 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with MSH2 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GAD High Level Gene-Disease Associations | diseases associated with MSH2 gene in GWAS and other genetic association datasets from the GAD High Level Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of MSH2 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MSH2 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MSH2 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of MSH2 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MSH2 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of MSH2 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MSH2 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of MSH2 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of MSH2 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving MSH2 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving MSH2 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving MSH2 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing MSH2 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing MSH2 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing MSH2 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by MSH2 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2023 | molecular functions performed by MSH2 gene from the curated GO Molecular Function Annotations 2023 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by MSH2 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of MSH2 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MSH2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of MSH2 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MSH2 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of MSH2 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with MSH2 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with MSH2 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with MSH2 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of MSH2 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of MSH2 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of MSH2 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of MSH2 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MSH2 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPO Gene-Disease Associations | phenotypes associated with MSH2 gene by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset. | |
| Hub Proteins Protein-Protein Interactions | interacting hub proteins for MSH2 from the curated Hub Proteins Protein-Protein Interactions dataset. | |
| HuGE Navigator Gene-Phenotype Associations | phenotypes associated with MSH2 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for MSH2 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of MSH2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of MSH2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MSH2 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| KEGG Pathways | pathways involving MSH2 protein from the KEGG Pathways dataset. | |
| KEGG Pathways 2026 | pathways involving MSH2 protein from the KEGG Pathways 2026 dataset. | |
| Kinase Library Serine Threonine Kinome Atlas | kinases that phosphorylate MSH2 protein from the Kinase Library Serine Threonine Atlas dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MSH2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of MSH2 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with MSH2 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of MSH2 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LINCS L1000 CMAP Chemical Perturbation Consensus Signatures | small molecule perturbations changing expression of MSH2 gene from the LINCS L1000 CMAP Chemical Perturbations Consensus Signatures dataset. | |
| LINCS L1000 CMAP CRISPR Knockout Consensus Signatures | gene perturbations changing expression of MSH2 gene from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset. | |
| LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MSH2 gene from the LINCS L1000 CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing MSH2 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain MSH2 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by MSH2 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MiRTarBase microRNA Targets | microRNAs targeting MSH2 gene in low- or high-throughput microRNA targeting studies from the MiRTarBase microRNA Targets dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MSH2 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MoTrPAC Rat Endurance Exercise Training | tissue samples with high or low expression of MSH2 gene relative to other tissue samples from the MoTrPAC Rat Endurance Exercise Training dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by MSH2 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| MSigDB Cancer Gene Co-expression Modules | co-expressed genes for MSH2 from the MSigDB Cancer Gene Co-expression Modules dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of MSH2 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of MSH2 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| NURSA Protein Complexes | protein complexs containing MSH2 protein recovered by IP-MS from the NURSA Protein Complexes dataset. | |
| OMIM Gene-Disease Associations | phenotypes associated with MSH2 gene from the curated OMIM Gene-Disease Associations dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for MSH2 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of MSH2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of MSH2 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PFOCR Pathway Figure Associations 2023 | pathways involving MSH2 protein from the PFOCR Pathway Figure Associations 2023 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving MSH2 protein from the Wikipathways PFOCR 2024 dataset. | |
| PID Pathways | pathways involving MSH2 protein from the PID Pathways dataset. | |
| ProteomicsDB Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of MSH2 protein relative to other cell types and tissues from the ProteomicsDB Cell Type and Tissue Protein Expression Profiles dataset. | |
| Reactome Pathways 2014 | pathways involving MSH2 protein from the Reactome Pathways dataset. | |
| Reactome Pathways 2024 | pathways involving MSH2 protein from the Reactome Pathways 2024 dataset. | |
| Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MSH2 gene from the Replogle et al., Cell, 2022 K562 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MSH2 gene from the Replogle et al., Cell, 2022 K562 Genome-wide Perturb-seq Gene Perturbation Signatures dataset. | |
| Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures | gene perturbations changing expression of MSH2 gene from the Replogle et al., Cell, 2022 RPE1 Essential Perturb-seq Gene Perturbation Signatures dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of MSH2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of MSH2 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MSH2 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of MSH2 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of MSH2 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sanger Dependency Map Cancer Cell Line Proteomics | cell lines associated with MSH2 protein from the Sanger Dependency Map Cancer Cell Line Proteomics dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of MSH2 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of MSH2 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of MSH2 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of MSH2 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of MSH2 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of MSH2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MSH2 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of MSH2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of MSH2 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores | tissues co-occuring with MSH2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with MSH2 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |
| Virus MINT Protein-Viral Protein Interactions | interacting viral proteins for MSH2 from the Virus MINT Protein-Viral Protein Interactions dataset. | |
| Virus MINT Protein-Virus Interactions | viruses interacting with MSH2 from the Virus MINT Protein-Virus Interactions dataset. | |
| WikiPathways Pathways 2014 | pathways involving MSH2 protein from the Wikipathways Pathways 2014 dataset. | |
| WikiPathways Pathways 2024 | pathways involving MSH2 protein from the WikiPathways Pathways 2024 dataset. | |